Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bacchetti

Showing results (171-180 of 246) with videos related to

Pageof 25
Sort By:
Plos One|January 15, 2014
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Albert Y Liu, Qiyun Yang, Yong Huang, et al.
AIDS Research and Human Retroviruses|March 25, 2017
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8<sup>+</sup> T Cell Exhaustion Marker ExpressionRachel Lena Rutishauser, Wendy Hartogensis, Christian Deo Deguit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Plos One|June 9, 2015
Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsSanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort StudyErin M Kelly, Jennifer L Dodge, Peter Bacchetti, et al.
The Journal of Infectious Diseases|April 27, 2012
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNALina Josefsson, Susanne Eriksson, Elizabeth Sinclair, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected WomenBani Tamraz, Yong Huang, Audrey L French, et al.
AIDS (London, England)|September 14, 2018
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoringCatherine A Koss, Albert Y Liu, Jose Castillo-Mancilla, et al.
Appetite|May 2, 2015
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trialAshley E Mason, Robert H Lustig, Rashida R Brown, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral TherapyJillian Pintye, Peter Bacchetti, Sirinya Teeraananchai, et al.
Pageof 25

Showing results (171-180 of 246) with videos related to

Sort By:
Pageof 25
Plos One|January 15, 2014
Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Albert Y Liu, Qiyun Yang, Yong Huang, et al.
AIDS Research and Human Retroviruses|March 25, 2017
Early and Delayed Antiretroviral Therapy Results in Comparable Reductions in CD8<sup>+</sup> T Cell Exhaustion Marker ExpressionRachel Lena Rutishauser, Wendy Hartogensis, Christian Deo Deguit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 22, 2019
Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care TestMonica Gandhi, Peter Bacchetti, Matthew A Spinelli, et al.
Plos One|June 9, 2015
Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected PatientsSanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Moderate Alcohol Use Is Not Associated With Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women: A Prospective Cohort StudyErin M Kelly, Jennifer L Dodge, Peter Bacchetti, et al.
The Journal of Infectious Diseases|April 27, 2012
Hematopoietic precursor cells isolated from patients on long-term suppressive HIV therapy did not contain HIV-1 DNALina Josefsson, Susanne Eriksson, Elizabeth Sinclair, et al.
Clinical Pharmacology and Therapeutics|September 29, 2019
Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected WomenBani Tamraz, Yong Huang, Audrey L French, et al.
AIDS (London, England)|September 14, 2018
Similar tenofovir hair concentrations in men and women after directly observed dosing of tenofovir disoproxil fumarate/emtricitabine: implications for preexposure prophylaxis adherence monitoringCatherine A Koss, Albert Y Liu, Jose Castillo-Mancilla, et al.
Appetite|May 2, 2015
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trialAshley E Mason, Robert H Lustig, Rashida R Brown, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 22, 2017
Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral TherapyJillian Pintye, Peter Bacchetti, Sirinya Teeraananchai, et al.
Pageof 25